Brilinta 90 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FJB8M
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $52,210
Award facts
- Contract value 100% obligated
- $52,210.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $52,210.21 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count packages). This competitive, non-set-aside contract was awarded on December 2, 2025, with an ultimate completion date of December 3, 2025, and is priced on a firm fixed-price basis. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Brilinta is a cardiovascular medication used for acute coronary syndrome and stroke prevention, representing the type of critical pharmaceutical commodity that supports military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999 ceiling value through December 2026. As a primary pharmaceutical vendor for federal medical supply chains, AmerisourceBergen supplies an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies to support Defense Health Agency operations and other government healthcare systems. The company's established relationship with DLA and proven capability to fulfill federal procurement requirements through open competition position it as a critical supplier for military pharmaceutical needs across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FJB8M?
SPE2DR26FJB8M was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26FJB8M worth?
The government has obligated $52,210 on SPE2DR26FJB8M.
Is contract SPE2DR26FJB8M an order under another contract?
Yes. SPE2DR26FJB8M is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJB8M competed?
The extent of competition for SPE2DR26FJB8M was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award